Cargando…

Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica

The parasitic helminth Fasciola hepatica secretes a 2-Cys peroxiredoxin (Prx) that may play important functions in host–parasite interaction. Recombinant peroxiredoxin (FhePrx) prevented metal-catalyzed oxidative nicking of plasmid DNA and detoxified hydrogen peroxide when coupled with Escherichia c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekiya, Mary, Mulcahy, Grace, Irwin, Jane A., Stack, Colin M., Donnelly, Sheila M., Xu, Weibo, Collins, Peter, Dalton, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Federation of European Biochemical Societies. Published by Elsevier B.V. 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127579/
https://www.ncbi.nlm.nih.gov/pubmed/16938293
http://dx.doi.org/10.1016/j.febslet.2006.08.019
_version_ 1783516390529957888
author Sekiya, Mary
Mulcahy, Grace
Irwin, Jane A.
Stack, Colin M.
Donnelly, Sheila M.
Xu, Weibo
Collins, Peter
Dalton, John P.
author_facet Sekiya, Mary
Mulcahy, Grace
Irwin, Jane A.
Stack, Colin M.
Donnelly, Sheila M.
Xu, Weibo
Collins, Peter
Dalton, John P.
author_sort Sekiya, Mary
collection PubMed
description The parasitic helminth Fasciola hepatica secretes a 2-Cys peroxiredoxin (Prx) that may play important functions in host–parasite interaction. Recombinant peroxiredoxin (FhePrx) prevented metal-catalyzed oxidative nicking of plasmid DNA and detoxified hydrogen peroxide when coupled with Escherichia coli thioredoxin and thioredoxin reductase (k(cat)/K(m) = 5.2 × 10(5) M(−1) s(−1)). Enzyme kinetic analysis revealed that the catalytic efficiency of FhePrx is similar to other 2-Cys peroxiredoxins; the enzyme displayed saturable enzyme Michaelis–Menten type kinetics with hydrogen peroxide, cumene hydroperoxide and t-butyl hydroperoxide, and is sensitive to concentrations of hydrogen peroxide above 0.5 mM. Like the 2-Cys peroxiredoxins from a related helminth, Schistosoma mansoni, steady-state kinetics indicate that FhePrx exhibits a saturable, single displacement-like reaction mechanism rather than non-saturable double displacement (ping–pong) enzyme substitution mechanism common to other peroxiredoxins. However, unlike the schistosome Prxs, FhePrx could not utilise reducing equivalents supplied by glutathione or glutathione reductase.
format Online
Article
Text
id pubmed-7127579
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Federation of European Biochemical Societies. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71275792020-04-06 Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica Sekiya, Mary Mulcahy, Grace Irwin, Jane A. Stack, Colin M. Donnelly, Sheila M. Xu, Weibo Collins, Peter Dalton, John P. FEBS Lett Article The parasitic helminth Fasciola hepatica secretes a 2-Cys peroxiredoxin (Prx) that may play important functions in host–parasite interaction. Recombinant peroxiredoxin (FhePrx) prevented metal-catalyzed oxidative nicking of plasmid DNA and detoxified hydrogen peroxide when coupled with Escherichia coli thioredoxin and thioredoxin reductase (k(cat)/K(m) = 5.2 × 10(5) M(−1) s(−1)). Enzyme kinetic analysis revealed that the catalytic efficiency of FhePrx is similar to other 2-Cys peroxiredoxins; the enzyme displayed saturable enzyme Michaelis–Menten type kinetics with hydrogen peroxide, cumene hydroperoxide and t-butyl hydroperoxide, and is sensitive to concentrations of hydrogen peroxide above 0.5 mM. Like the 2-Cys peroxiredoxins from a related helminth, Schistosoma mansoni, steady-state kinetics indicate that FhePrx exhibits a saturable, single displacement-like reaction mechanism rather than non-saturable double displacement (ping–pong) enzyme substitution mechanism common to other peroxiredoxins. However, unlike the schistosome Prxs, FhePrx could not utilise reducing equivalents supplied by glutathione or glutathione reductase. Federation of European Biochemical Societies. Published by Elsevier B.V. 2006-09-18 2006-08-22 /pmc/articles/PMC7127579/ /pubmed/16938293 http://dx.doi.org/10.1016/j.febslet.2006.08.019 Text en Copyright © 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sekiya, Mary
Mulcahy, Grace
Irwin, Jane A.
Stack, Colin M.
Donnelly, Sheila M.
Xu, Weibo
Collins, Peter
Dalton, John P.
Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica
title Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica
title_full Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica
title_fullStr Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica
title_full_unstemmed Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica
title_short Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica
title_sort biochemical characterisation of the recombinant peroxiredoxin (fheprx) of the liver fluke, fasciola hepatica
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127579/
https://www.ncbi.nlm.nih.gov/pubmed/16938293
http://dx.doi.org/10.1016/j.febslet.2006.08.019
work_keys_str_mv AT sekiyamary biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica
AT mulcahygrace biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica
AT irwinjanea biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica
AT stackcolinm biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica
AT donnellysheilam biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica
AT xuweibo biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica
AT collinspeter biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica
AT daltonjohnp biochemicalcharacterisationoftherecombinantperoxiredoxinfheprxoftheliverflukefasciolahepatica